On 28 and 29 November 2018, the European Innovation Council (EIC) and Medtronic, a leader in the world of medical technology, gathered 20 companies to discuss the transformation of healthcare and promote business partnerships. decide Clinical Software shared its solution “GlucoTab” for blood glucose management.
Small and medium enterprises (SMEs) have been playing an increasingly crucial role in the development of new products in the medical device industry. Quick adaptability, the capacity to identify market niches and intrinsic innovative potential, have turned these companies into relevant players in the healthcare industry worldwide.
However, at the stage when SMEs are growing, they need considerable financial resources to continue investments in product development and clinical trials, to bring their products to market faster. To tackle these challenges the EIC pilot and Medtronic promoted a matchmaking and business acceleration event in Tolochenaz, Switzerland, home of Medtronic’s EMEA headquarters.
decide Clinical Software was one of the 20 companies backed by the EIC pilot that took the stage and shared their innovative health care solutions for medical devices and therapies, mobile and remote health, patient engagement, diagnostics, artificial intelligence, augmented and virtual reality, data analytics and robotics.
At the event, Ger Hill, Senior Director Global Innovation at Medtronic, talked about Medtronic’s innovation strategy: “For a company like Medtronic who has currently reached around 30B$ in revenue, maintaining revenue growth requires us to draw on innovation not only from our substantial organic internal innovation, but also from external partners. There are a lot of smart people who don’t work at Medtronic, and we want to collaborate with them to turn their ideas and concepts into products and solutions for patients and Medtronic.”
“It was a pleasure participating in this event. The quality of the presentations was very high, and we felt that also the Medtronic participants were impressed and interested. We had very promising discussions with different business areas of Medtronic, and we believe that GlucoTab could play a relevant role in different ways.”, says CTO Peter Beck.